NCT00224523
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +7 more
- Locations
-
- GSK Investigational Site Leuven, Belgium
- GSK Investigational Site Amsterdam, Netherlands
- GSK Investigational Site Nijmegen, Netherlands
- GSK Investigational Site The Hague, Netherlands